Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400082658Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in None (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Sedation success rate and Overall incidence of adverse events. Planned start Apr 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400082658.